# LMRI — Lumexa Imaging Holdings Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** LMRI  
**Sources:** 22  
**Published:** 2026-10-27  
**Canonical:** https://app.k3vl4r.com/research/deep-research-lmri-lumexa-imaging-holdings-inc-catalysts-narrative-ris-9641

---

## Lumexa Imaging Holdings Inc. (NASDAQ: LMRI) — Research Note as of 2026-10-27

*Not investment advice. All figures are point-in-time from third-party sources and may contain inconsistencies (see critical reflection at the end).*

### Company Snapshot
As of Oct 27, 2026, LMRI trades on NASDAQ at ~$11.67, with a market cap of ~$1.12B and ~96.07M shares outstanding [[17]](https://stockanalysis.com/stocks/lmri/). It is one of the largest U.S. outpatient imaging operators, described as having the second-largest diagnostic imaging footprint in the U.S., operating roughly 180–190 centers across 13 states, 85+ of which are joint ventures (JVs) with major health systems [[8]](https://www.williamblair.com/News/Lumexa-Imaging-Holdings-Inc-Initiation), [[22]](https://sjra.com/lumexa-imaging/), [[24]](https://www.linkedin.com/company/lumexa-imaging). The stock has underperformed, down ~36.5% year-to-date, within a 52-week range of $6.45–$19.45 [[14]](https://tickernerd.com/stock/lmri-forecast/), [[17]](https://stockanalysis.com/stocks/lmri/).

### Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-lmri-lumexa-imaging-holdings-inc-catalysts-narrative-ris-9641 (free to sign up)._